Welcome to our dedicated page for Quantum-Si SEC filings (Ticker: QSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Quantum-Si's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Quantum-Si's regulatory disclosures and financial reporting.
Quantum-Si, Incorporated entered a new long-term lease for approximately 54,374 square feet of planned office, laboratory and manufacturing space in San Diego, California. The 10-year term is expected to begin around September 1, 2027, with a latest possible start of November 1, 2027.
Initial monthly base rent is about $315,369.20, or $5.80 per square foot, increasing roughly 3% each year. Base rent is fully abated for the first 20 months after commencement. The landlord will provide up to $17,127,810 as a tenant improvement allowance, while Quantum-Si pays prepaid rent of $434,448.26 and posts a $2,085,786.64 letter-of-credit security deposit. The lease supports ongoing development of the Proteus™ platform and expanded manufacturing capabilities and replaces existing San Diego space expected to expire on December 31, 2027.
Quantum-Si Inc. notified Nasdaq of the voluntary withdrawal of its warrant class from listing and registration on the Nasdaq Stock Market LLC pursuant to Rule 12d2-2. Nasdaq certified it followed exchange procedures and filed the Form 25 through an authorized representative.
Quantum-Si Inc director Brigid Makes reported a new stock option grant and her current share holdings. She received a grant of 251,185 Stock Options (right to buy) Quantum-Si Class A Common Stock at an exercise price of $0.8539 per share, expiring on May 18, 2036. According to the footnote, the shares underlying this option vest on the date of Quantum-Si’s next regular annual stockholders meeting, subject to her continued service through that vesting date. Following this grant, she holds 20,512 shares of Class A Common Stock directly, along with the 251,185 options.
Quantum-Si Inc director Ruth A. Fattori reported an equity compensation grant in the form of stock options. She received options covering 251,185 shares of Class A Common Stock at an exercise price of $0.8539 per share, expiring on May 18, 2036.
The options relate to 251,185 underlying Class A shares and were granted as a “right to buy.” According to the footnote, the shares underlying this option vest on the date of Quantum-Si’s next regular annual stockholders meeting, subject to her continued service. Following the reported transactions, she directly holds 170,512 shares of Class A Common Stock.
Quantum-Si Inc director Paula Dowdy reported a new stock option grant. She received a Stock Option (right to buy) covering 251,185 shares of Class A Common Stock at a conversion or exercise price of $0.8539 per share, expiring on May 18, 2036.
The filing states that the shares underlying this option vest on the date of Quantum-Si’s next regular annual stockholders meeting, subject to her continued service through that vesting date. After the reported transactions, she directly beneficially owns 269,107 shares of Class A Common Stock.
Quantum-Si Inc director Amir Jafri reported a new stock option grant. He received an option covering 251,185 shares of Class A Common Stock at an exercise price of $0.8539 per share, expiring on May 18, 2036. The shares underlying this option vest on the date of the issuer's next regular annual stockholders meeting, subject to continued service through that date. Following the reported transactions, he holds 115,942 shares of Class A Common Stock directly, with no open-market purchases or sales reported.
Quantum-Si Inc director John P. Kenny received a new stock option award, giving him the right to buy 251,185 shares of Class A Common Stock at an exercise price of $0.8539 per share. This option expires on May 18, 2036 and the underlying shares vest on the date of the company’s next regular annual stockholders meeting, subject to his continued service through that vesting date. Following the reported transactions, he directly holds 114,285 shares of Class A Common Stock in addition to this new option grant.
Quantum-Si Inc director Kevin Rakin received a grant of stock options for 251,185 shares of Class A common stock at an exercise price of $0.8539 per share. These options expire on May 18, 2036 and vest on the date of the issuer's next regular annual stockholders meeting, subject to continued service.
Following the reported transactions, Rakin holds 20,512 Class A shares directly and 1,200,000 shares indirectly through investment entities with which he shares voting and investment discretion. The new option award adds to this equity exposure as compensation rather than an open‑market purchase.
Quantum-Si Inc director Scott Mendel reported an equity award. He received a grant of 251,185 stock options to buy Class A Common Stock at an exercise price of $0.8539 per share, expiring on May 18, 2036.
The options cover 251,185 underlying Class A shares and vest on the date of Quantum-Si’s next regular annual stockholders meeting, subject to his continued service through that vesting date. After this filing, he directly holds 141,843 shares of Class A Common Stock and 251,185 options.
Quantum-Si Inc director Charles R. Kummeth reported a new equity award and updated holdings. He received a grant of 251,185 stock options, each giving the right to buy one share of Class A Common Stock at an exercise price of $0.8539 per share. These options expire on May 18, 2036 and the shares underlying the option vest on the date of the issuer's next regular annual stockholders meeting, subject to continued service through that vesting date. Following this filing, he directly holds 855,000 shares of Class A Common Stock, alongside the newly granted options. This award is compensation-related and does not reflect an open-market purchase or sale.